Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved for the treatment of adults with severe AA. As a better under...

Descripción completa

Detalles Bibliográficos
Autores principales: Egeberg, Alexander, Linsell, Louise, Johansson, Erin, Durand, Frederick, Yu, Guanglei, Vañó-Galván, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689337/
https://www.ncbi.nlm.nih.gov/pubmed/37833617
http://dx.doi.org/10.1007/s13555-023-01044-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689337/
https://www.ncbi.nlm.nih.gov/pubmed/37833617
http://dx.doi.org/10.1007/s13555-023-01044-5

Ejemplares similares